Espelt MV, de Tezanos Pinto F, Alvarez CL, Alberti GS, Incicco J, Denis MF, Davio C, Schwarzbaum PJ. On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells. Am J Physiol Cell Physiol 304: C1013-C1026, 2013. First published March 13, 2013 doi:10.1152/ajpcell.00254.2012.-Hypotonicity triggered in human hepatoma cells (Huh-7) the release of ATP and cell swelling, followed by volume regulatory decrease (RVD). We analyzed how the interaction between those processes modulates cell volume. Cells exposed to hypotonic medium swelled 1.5 times their basal volume. Swelling was followed by 41% RVD 40 (extent of RVD after 40 min of maximum), whereas the concentration of extracellular ATP (ATP e) increased 10 times to a maximum value at 15 min. Exogenous apyrase (which removes di-and trinucleotides) did not alter RVD, whereas exogenous Na ϩ -K ϩ -ATPase (which converts ATP to ADP in the extracellular medium) enhanced RVD 40 by 2.6 times, suggesting that hypotonic treatment alone produced a basal RVD, whereas extracellular ADP activated RVD to achieve complete volume regulation (i.e., RVD40 Ϸ100%). Under hypotonicity, addition of 2-(methylthio)adenosine 5=-diphosphate (2MetSADP; ADP analog) increased RVD to the same extent as exposure to Na ϩ -K ϩ -ATPase and the same analog did not stimulate RVD when coincubated with MRS2211, a blocker of ADP receptor P2Y 13. RT-PCR and Western blot analysis confirmed the presence of P2Y 13. Cells exhibited significant ectoATPase activity, which according to RT-PCR analysis can be assigned to ENTPDase2. Both carbenoxolone, a blocker of conductive ATP release, and brefeldin A, an inhibitor of exocytosis, were able to partially decrease ATP e accumulation, pointing to the presence of at least two mechanisms for ATP release. Thus, in Huh-7 cells, hypotonic treatment triggered the release of ATP. Conversion of ATP e to ADPe by ENTPDase 2 activity facilitates the accumulated ADP e to activate P2Y13 receptors, which mediate complete RVD.
cell volume regulation; human hepatoma; nucleotides; P2Y13 receptor; purinergic signaling IN MOST ANIMAL CELLS, A REDUCTION of extracellular osmolarity or an increase in intracellular osmolarity leads to a net influx of water causing volume increase. Not surprisingly, cells exhibit volume regulatory mechanisms that prevent excessive swelling leading to cell bursting and excessive shrinkage that would compromise proper cell metabolism (24) . Cell swelling is followed by a slower recovery towards the preshock level, a process known as regulatory volume decrease (RVD; Refs. 27, 38) . This response is mediated to a large extent by the efflux of intracellular osmolytes, thereby generating a driving force for water efflux. Swollen cells of liver and hepatoma cells lose Cl Ϫ and K ϩ through electroneutral ion transport pathways or by the separate activation of K ϩ and anion channels (27) . Although many intracellular signaling processes of cell volume regulation are now well characterized (29) , comparatively little is known regarding the extracellular factors controlling RVD (14, 48, 49) . In this respect, mechanical stimuli such as shear stress (7), mechanical strain (55) , and hypotonic stress (45) have been shown to induce the release of ATP in the absence of lysis from a variety of cells (36, 44, 51, 52, 61) , whereas addition of exogenous ATP to hypotonic cells suspensions was able to stimulate RVD (32, 49) . In principle ATP can be released both by a conductive channel-mediated pathway, driven by the steep electrochemical gradient of ATP through the plasma membrane, and by vesicular transport via exocytosis (19, 22, 23, 40) . In liver cells, increases in cell volume of both cholangiocytes and human cholangiocarcinoma trigger parallel changes in vesicular exocytosis and ATP release, whereas in rat hepatoma cells intracellular ATP is localized in discrete vesicles originated from a bafilomycin A1-sensitive pool that are depleted by hypotonic exposure, thus implying an important role of exocytosis in regulated release of ATP from hepatic cells (22) .
Examples of ATP-induced volume regulation were observed in hepatocytes, hepatoma (21, 23, 61) , endothelial cells, astrocytes, and epithelial cells from human and several other mammalian species (6, 7, 36) . Similarly, swollen cells could be induced to downregulate their volume in the presence of nucleotides other than ATP, such as UTP, UDP, or ATP␥S (but not ADP) in fish hepatocytes (9, 10 17, 49) , and UTP in salivary gland duct cells (33) .
In general, the action of extracellular ATP (ATP e ) and other nucleotides on RVD requires the activation of cell surface purinergic receptors called P2 (type 2 receptors for purinic and pyrimidinic di-and trinucleotides; Ref. 39) . The P2 receptor family (12) consists of two main subtypes, P2X and P2Y, representing ligand-gated cation channels and G protein-coupled receptors, respectively. Whereas P2X receptors respond only to ATP, P2Y receptors can be activated by ATP, ADP, UTP, UDP, ITP, and nucleotide sugars, although specificity varies among subtypes (1) . Activation of some P2 receptor subtypes (P2Y 2 , P2Y 4 , P2Y 6 , and P2Y 11 ) is coupled to increases in intracellular Ca 2ϩ (via activation of G q /G 11 protein), while other subtypes (P2Y1, P2Y 12 , P2Y 13 , and P2Y 14 In rat hepatoma cells and human hepatocytes, ATP e couples increases in cell volume to stimulation of Cl Ϫ permeability via activation of specific P2Y receptors subtypes (21, 53, 61) .
In spite of the accumulated knowledge showing how activation of P2 receptors by extracellular nucleotides regulates the permeability of osmolytes and cell volume, the role of extracellular metabolism of these nucleotides on the RVD response remained largely unexplored. This is important since signaling of specific P2 receptor subtypes modulating the RVD will depend on the time-dependent changes in the concentrations of nucleotides and its hydrolysis products on the cell surface.
Accordingly, ATP can be metabolized extracellularly by a family of ectonucleotidases that restrain the action of ATP e on certain P receptors, while at the same time generate different byproducts (notably ADP and adenosine) that can accumulate at the cell surface and signal, autocrinally and paracrinally, via specific P receptors subtypes. In many tissues and cells, members of the ectonucleoside triphosphate diphosphohydrolase (ENTPDase) family (EC 3.6.1.5) comprise the dominant ectonucleotidases controlling the hydrolysis of nucleoside diphosphates and triphosphates (15, 52, 62) . Some human and murine hepatoma cell lines express high levels of ENTPDase 2, which displays high ectoATPase activity and low ectoADPase activity. Under these conditions, ADP is thought to accumulate whereas adenosine production is delayed (37) . Although adenosine has been shown to stimulate RVD of human erythrocytes (48) , there are currently no reports, for any type of cell, of extracellular ADP affecting RVD.
In the present study we used Huh-7 hepatoma cells to determine whether ATP release, ATP e hydrolysis, P receptor signaling, and RVD are functionally related. Our approach included an assessment of time-dependent volume changes of cells exposed to hypotonicity, the kinetics of ATP e accumulation, and the extracellular hydrolysis of this nucleotide. Furthermore, RT-PCR was used to detect mRNAs of the main P receptor(s) and ENTPDase(s) involved in RVD control. Finally, we developed a simple data-driven mathematical model to account for the kinetics of ATP e of swollen hepatoma cells.
Our results show that two mechanisms allow intracellular ATP to be released from Huh-7 hepatoma cells during hypotonic swelling and that ADP e , derived from ATP e hydrolysis, can activate P2Y 13 receptor to potentiate RVD.
MATERIALS AND METHODS

Chemicals
Cibacron blue 3GA, suramin, poly-L-lysine, apyrase (grade III), 2-(methylthio)adenosine 5=-diphosphate (2MetSADP), forskolin, luciferin, and luciferase were purchased from Sigma (St. Louis, MO). The acetoxymethyl (AM) esters of calcein and fura-2 were obtained from Molecular Probes (Eugene, OR). [␥ For Western blot analysis of P receptors, the anti-human P2Y 13 polyclonal antibody was purchased from Abcam (ab75103; Abcam, Cambridge, MA), and the anti-␤ tubulin antibody was from Sigma (St. Louis, MO). Immunoreactive bands were detected by chemiluminiscence (Amersham ECL plus Western Blotting Detection Reagents; GE Healthcare).
Purified Na ϩ -K ϩ -ATPase from pig kidney outer medulla was kindly provided by Dr. Monica Montes (IQUIFIB, School of Biochemistry and Pharmacy, University of Buenos Aires). It was prepared by the procedure of Jensen et al. (31) . The enzyme had a specific activity of 8 U/mg. All other reagents were of analytical grade.
For RT-PCR analysis we used the following reagents: RNA isolation kit (Qiagen RNeasy, Hilden, Germany), reverse transcriptase M-MLV (Life Technologies, Berlin, Germany), Taq DNA polymerase (PB-L, Bio-Lógicos, Argentina-Brasil), and 1 M of sense and antisense primers (Life Technologies, Berlin, Germany).
Cell Culture
Human hepatoma cells Huh-7 cells were cultured in DMEM supplemented with 10% vol/vol FBS and antibiotics (100 U/ml penicillin; 100 g/ml streptomycin) in a humidified atmosphere of 5% CO2 at 37°C. The viability was routinely assessed by retention of calcein and fura-2 using quantitative epifluorescence microscopy (20) . No loss of cell viability was detected when Huh-7 cells were exposed to the different treatments used in this study.
Experimental Media
Cells were incubated during 45 min at 20°C in control isotonic medium (denoted as C) with the following composition (mM): 20 HEPES; 130 NaCl, 4.7 KCl, 1.5 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, 5 NaHCO3, 10 glucose, and 300 mosM osmolarity. (pH 7.4 at 20°C). Hypotonic medium (denoted as H) was prepared by mixing one volume of medium C with one volume of medium D (medium C without NaCl), yielding an osmolarity of 180 mosM.
The osmolarity of all media was measured with a vapor pressure osmometer (5100 B; Wescor, Logan, UT).
Cell Volume
The technique was described in detail in previous reports (20, 49) . Briefly, changes in cell water volume were inferred from readings of the fluorescence intensity recorded at 510 nm by exciting calcein at 495 nm. Hepatoma cells (5 ϫ 10 4 ) were plated on 25-mm-diameter glass coverslips previously coated with poly-L-lysine. Each coverslip with attached cells was mounted on a perfusion chamber filled with medium C and placed on the stage of a Nikon TE-200 epifluorescence inverted microscope. Cells were loaded with 4 M of calcein-AM for 1 h at room temperature.
Calcein-AM is nonfluorescent but, once loaded into cells, is cleaved by endogenous esterases to produce calcein, a highly fluorescent and well-retained dye.
Temporal changes in fluorescence intensity recorded from a small region of dye-loaded cells reflect changes in intracellular fluorophore concentration and, therefore, alterations of cell water volume (3, 4) . Fluorescent images were acquired by using a charge coupled device camera (Hamamatsu C4742-95) connected to a computer and the Metafluor acquisition software (v. 5.0; Universal Imaging).
Experimental medium volume was 300 ul, except in experiments (see Fig. 5C ), where "small volume" denotes an assay volume of 100 ul.
Values of Vr at different time points were computed from monitored changes in relative fluorescence (Ft/Fo), with Fo representing the signal obtained from a pinhole region of the cell equilibrated with isotonic medium, and Ft denoting the fluorescence of the same region of the cell at time t. Thus Vr represents a fractional volume, where volume before treatments is one, and volume changes are related to this value.
Data of Vr vs. time were used to estimate the extent of volume regulation or RVD, which was calculated as follows (see Ref. 
Nucleotide Scavengers
Na ϩ -K ϩ -ATPase (5 U/ml) and apyrase (20 U/ml) dissolved in medium H were used as scavengers of extracellular nucleotides by accelerating the conversion from ATP to ADP ϩ Pi (Na ϩ -K ϩ -ATPase) and from NTP to NMP ϩ 2 Pi (apyrase), where NTP, NDP, and NMP stand for nucleoside tri-, di-, and monophosphate, respectively (50) .
Agonists and Antagonists of P2 Receptors
The involvement of P2 receptors modulating RVD was characterized by using 1 M 2MetSADP as a P2Y 13 agonist, 100 M cibacron blue 3GA ϩ 100 M suramin (Cb ϩ S) as P2Y antagonists, and 50 M of MRS2211 as P2Y13 antagonist.
EctoATPase Activity
Cell membranes are generally impermeable to low micromolar ATP concentrations added exogenously (57) . Thus, when culture intact cells are used, any hydrolysis of extracellular ATP into ADP ϩ P i can be defined as ectoATPase activity and can be assigned to one or more membrane proteins of the ENTPDase superfamily (62). Thus we used an ATPase assay to determine the rate at which intact hepatoma cells hidrolyze the ␥-terminal P i of extracellular ATP (57 
where Y and Y 0 are the values of Pi at any time (t) and that at t ϭ 0, A represents the maximal value for the increase of Y with time, and k is a rate coefficient. The parameters of best fit resulting from the regression were used to calculate the initial rate of ATP hydrolysis (vi) as vi ϭ k ϫ A (i.e., by taking the first derivative of Eq. 2 for t tending to zero). Exposure of cells to 100 M POM-1 was used to inhibit ectoATPase activity.
Cytosolic Free Ca 2ϩ
Changes in the concentration of cytosolic free calcium ([Ca 2ϩ ]i) were determined by loading hepatoma cells with 6 M of the Ca 2ϩ sensitive fluorescent dye fura-2 AM. The procedure for fluorophore cell loading and extracellular washout, addition and removal of media, and acquisition of fluorescence intensity using a double-wavelength excitation system was described before (3) . Briefly, 5 ϫ 10 4 cells loaded with fura-2 were excited to alternate illumination at 340 and 380 nm and fluorescent emission images were recorded at 510 nm. The ratio 340/380 of the fluorescence intensities was calculated.
cAMP Assay
Two million cells were seeded in six-well plates in DMEM ϩ FBS. After 24 h, the medium was removed and medium H supplemented with each treatment drug was added for 5 min. For cAMP extraction, medium was discarded and ethanol was added. The ethanol phase was dried and resuspended in 50 mM Tris·HCl, pH 7.4 and 0.1% BSA. cAMP was determined by competition of [ 3 H]cAMP for protein kinase A, as described previously (16) . Forskolin (1 M) was used to promote an increase in cAMP concentration.
RT-PCR Analysis
This technique was used to detect mRNAs of ENTPDases (subtypes 1-1, 1-2, 2, 3, and 8) and P2Y receptors (subtypes 12 and 13).
Total RNA was extracted from confluent cultures of Huh-7. Synthesis of cDNA was performed using reverse transcriptase M-MLV (Life Technologies, Berlin, Germany) and random primers. PCR reactions were carried out in a 50-l reaction volume containing the following reagents: 3 l of cDNA preparation; 20 mM Tris·HCl, pH 8.0; 50 mM KCl; 1 mM MgCl 2; 0.25 mM of dATP, dGTP, dCTP, and dTTP; 5 U of Taq DNA polymerase, and 1 M of sense and antisense primers. PCR was performed on a MasterCycler (Eppendorf, Hamburg, Germany), using the following conditions for denaturation, annealing, and extension (35 cycles): 95°C for 30 s, 55°C for 45 s, and 72°C for 1 min, followed by 72°C for 10 min. PCR products were separated by electrophoresis on a 2% agarose gel stained with ethidium bromide.
The specific primers sequences were as follows: 1) for human ENTPDase 1-1 5=-gagagggagagagagatgaagag-3=and 5=-gttctgggtcaaccccacag-3=; 2) for human ENTPDase 1-2, 5=-ctccagttttggtgctgtgaac-3=and 5=-gttctgggtcaaccccacag-3=; 3) for human ENTPDase 2, 5=-tggaggcagccgcagtgaatgt-3=and 5=-ggaggcgaagagcagcaggaggac-3=; 4) for human ENTPDase 3, 5=-accttcaactccagcacctg-3=and 5=-gtcaaaggcatgctcggagtg-3=; 5) for human ENTPDase 8, 5=-cccccagaacctcacagttg-3=and 5=-acccagacgccgtagctctc-3=; 6) for human P2Y 12, 5=-ccactctgcaggttgcaata3=and 5=-taaatggcctggtggtcttc-3=; 7) for human P2Y13, 5=-ccagccctctacacagtggt-3=and 5=-gatcgtatttggcagggaga-3=; and 8) for human plasma membrane Ca 2ϩ -ATPase (PMCA), 5=-cctcccctgtggaaggtctgtctg-3=and 5=-tggttggtgttagagtcggtgtccctcgacctact-3=. The expected sizes of the PCR products were 485 bp for human ENTPDase 1-1, 200 bp for human ENTPDase 1-2, 314 bp for human ENTPDase 2-1, 245 bp for human ENTPDase 2-2, 402 bp for human ENTPDase 3, 504 bp for human ENTPDase 8-1, 393 bp for human ENTPDase 8-2, 475 bp for human P2Y 12, 399 bp for human P2Y13, and 413 bp for human PMCA. PMCA was used as positive control.
Western Blot Analysis
Cells were incubated in cold lysis buffer (500 mM Tris·HCl pH 8, 150 mM NaCl, 1% Triton X-100, 5 mM EDTA, 0.1 mg/ml aprotinin, and 2 mM PMSF) 45 min, with vortexing every 5 min. Finally, samples were centrifuged at 12,000 g at 4°C for 10 min and supernatants were collected. P2Y 13 expression was determined in cell lysates; 20 ug of total protein were resolved by 10% SDS-PAGE. For immunoblotting, proteins were transferred to polyvinylidene fluoride membranes, which were then probed with an anti-human P2Y 13 polyclonal antibody (1:1,000) overnight at 4°C, followed by a 60-min incubation with horseradish peroxidase-conjugated secondary antibody. Protein loading in gels was evaluated by incubating membranes with an anti-␤-tubulin antibody (1:1,000). Immunoreactive bands were detected by chemiluminiscence and quantified by densitometric analysis using ImageJ software (National Institutes of Health).
Measurement of ATP e
The concentration of ATPe was measured using firefly luciferase (EC 1.13.12.7), which catalyzes the oxidation of luciferin in the presence of ATP to produce light (11, 57).
Measurements were performed using 5 ϫ 10 4 cells loaded on poly-L-lysine-coated coverslips which were mounted on a chamber of a custom-built luminometer, as described earlier (49) . The setup allowed continuous measurements of ATP e to be taken via the light output detection of the luciferin-luciferase reaction. Measurements were performed in 40 ul of experimental media (under the experimental conditions assay volume did not change with time), so that the medium has a height of ϳ104 m (height at the coverslip bottom of the chamber equals 0). As shown by Okada et al. (46) , measurements of ATP using this small volume provide similar results as the measurement of ATP at the cell surface using a surface-attached chimeric luciferase.
The time course of light emission was transformed into ATP e concentration vs. time by means of a calibration curve by adding known exogenous ATP concentrations (0 -200 nM). Calibration curves displayed a linear relationship within the range tested. Because luciferase activity at 37°C is only 10% of that observed at 20°C, to maintain full luciferase activity real-time ATP measurements were performed in a cool chamber acclimated at 20°C.
Measurement of ADP e
The technique is based on the use of pyruvate kinase (PK) catalyzing the following reaction:
The general idea is that all ADP present in the extracellular medium of a sample containing intact cells can be converted to ATP by PK; thus total ATP (ATP T, the ATP present in the extracellular medium plus the ADP that was converted into ATP by PK) can be measured by the luciferin-luciferase reaction described above. By running separate measurements, in paired samples, of ATP T and of ATP alone, the difference between these two provides an estimate of the ADPe concentration.
Accordingly, 5 ϫ 10 4 cells were seeded on coverslips using an experimental volume of 50 l. At fixed time points, two 20-l paired samples from the extracellular medium were taken. One of these samples was used for regular ATP measurements (sample 1), while the second sample was incubated 5 min at room temperature in the presence of PK (3 U) and 100 M phosphoenolpyruvate to convert all ADP into ATP (ATP T; sample 2). In both samples, the ATP concentration was measured by luminescence emission as described above. Values of ADP e concentration were obtained by calculating ATPT concentration from sample 2 minus ATP concentration from sample 1 (13) .
Statistics
The effect of the different treatments on RVD was evaluated by means of one-way ANOVA followed by a Tukey-Kramer test of multiple comparisons. P Յ 0.05 was considered significant. For all experiments of Vr vs. time, 15-20 cells from 4 -5 independent preparations were used. Figure 1 shows time-dependent changes in Vr (volume relative to isotonic volume) for Huh-7 human hepatoma cells exposed to different experimental conditions. Under isotonic conditions (C) Vr remained constant, whereas exposure to a hypotonic medium (H) triggered a fast increase of Vr to a maximum (1.53 Ϯ 0.04) followed by a slower volume decrease with RVD 40 ϭ 40.8 Ϯ 7.80%. In similar experiments using a more prolonged hypotonic exposure (up to 130 min), cell volume achieved a steady state at Vr ϭ 1.26 Ϯ 0.03 after 60 min (data not shown).
RESULTS
Volume Regulation of Huh-7 Cells
In hypotonic medium plus apyrase (20 U/ml), on the other hand, the extent of volume regulation (RVD 40 ϭ 42.2 Ϯ 9.71%) was not significantly different from that obtained in hypotonic medium alone, suggesting that extracellular di-and trinucleotides had no effect on RVD. Exposure of cells to hypotonic medium with 100 M cibacron blue and 100 M suramin (Cb ϩ S, two well-known blockers of most P2 receptors) reduced RVD 40 by 88% (RVD 40 ϭ 11.9 Ϯ 3.17%).
On the other hand when exogenous Na ϩ -K ϩ -ATPase (5 U/ml), which promotes the extracellular conversion of ATP to ADP, was used combined with hypotonic medium, RVD 40 amounted to 106.1 Ϯ 14.3% (P Ͻ 0.01).
Up to here blockage of RVD by Cb ϩ S would indicate that P2 receptors are important factors modulating the regulation of cell volume of hypotonically challenged Huh-7 cells. However, if this were true, then apyrase (which scavenges extracellular di-and trinucleotides) should inhibit RVD, but it did not. Moreover, Na ϩ -K ϩ -ATPase not only did not inhibit but en- hanced RVD, indicating that ADP e might be an important factor activating volume regulation. The experiments below were designed to clarify these issues.
Effects of Glibenclamide on RVD
The P2 blockers cibacron blue and suramin were reported to inhibit volume sensitive Cl Ϫ channels (28, 29) , so that the observed inhibition of RVD by both P2 blockers might be due to inhibition of Cl Ϫ permeability. Accordingly, incubation of Huh-7 in hypotonic medium with the chloride channel blocker glibenclamide (400 M) inhibited RVD to a similar extent than medium H ϩ Cb ϩ S (RVD 40 ϭ 17.5 Ϯ 2.53 and 11.9 Ϯ 3.17%, respectively; Fig. 2, A and B) .
Glibenclamide has been shown to block cystic fibrosis transmembrane conductance regulator-dependent ATP efflux in various cell types (5) . Thus, to discard that the observed effects of glibenclamide on Vr were due to blockage of ATP e accumulation, cells were exposed to hypotonic medium with glibenclamide ϩ 75 nM ATP. This ATP concentration is about twice the peak concentration of endogenous ATP e obtained after hypotonic exposure of Huh-7 hepatoma cells. As shown in Fig. 2B , RVD 40 in the presence of glibenclamide was similar in the absence or presence of exogenous ATP.
Effects of Extracellular ADP on RVD
If, under hypotonic exposure of Huh-7 cells, exogenous Na ϩ -K ϩ -ATPase is enhancing RVD by facilitating ADP e production from released ATP, then ADP e or an ADP analog should also activate RVD. Accordingly, exposure of cells to medium H in the presence of 1 M of the ADP agonist 2MetSADP induced a complete volume regulation (RVD 40 ϭ 107.9 Ϯ 17.16%) that did not differ from that obtained in hypotonic medium containing Na (Fig. 3, A and B) . After preincubating cells in isotonic medium with 5 M MRS2211, a blocker of ADP receptor P2Y 13 , followed by cells exposure to medium H ϩ 2MetSADP ϩ MRS2211, RVD 40 amounted to 49.2 Ϯ 5.94%, a value not significantly different to that obtained in the presence of medium H alone (Fig. 3, A  and B) .
Of the three known P receptors for ADP (P2Y 1 , P2Y 12 , and P2Y 13 ), P2Y 1 was reported to be nonfunctional in Huh-7 cells (56) . Reverse transcriptase analysis showed the presence of mRNA for the P2Y 13 receptor but not for P2Y 12 (Fig. 3C) , and Western blot analysis confirmed the presence of P2Y 13 in these cells (Fig. 3D) .
Volume Regulation and Intracellular Signaling
Time-dependent changes in cytosolic free calcium (Ca i 2ϩ ) were assessed continuously by fluorescence microscopy. For cells preincubated in isotonic medium, exposure to hypotonic medium in the absence or presence of 2MetSADP produced only a minor change in [Ca 2ϩ ] i concentration (Fig. 4, A and B) , thus confirming that P2Y 1 receptor is not functional in these cells.
As shown in Fig. 3 , we identified the P2Y 13 receptor in Huh-7 cells. The transduction mechanism of this ADP receptor subtype requires G i/o activation (1, 12) , which might lead to inhibition of adenylyl cyclases, causing a decrease of cAMP concentration.
However, the concentration of cAMP in hypotonic medium did not change when 2MetSADP (activating P2Y 13 ) was present in cells exposed to hypotonic medium (Fig. 4C) . Moreover, incubation of cells in hypotonic medium with forskolin (an activator of adenylyl cyclases) increased cAMP concentration sixfold, and this increase was not altered by 1 M 2MetSADP.
Release of ATP and ADP e Accumulation in Huh-7 Cells Under Hyposmolarity
Since exogenous Na ϩ -K ϩ -ATPase activity induced full RVD by promoting ATP e ¡ ADP e conversion, we wondered whether the hypotonic challenge would be the mechanism enabling the release of ATP, with the resulting ATP e being used as a substrate to generate ADP e .
Incubation of Huh-7 cells in hypotonic medium triggered ATP release, so that ATP e concentration increased acutely Next, 10 M carbenoxolone was used to block a conductive pathway of ATP release mediated by pannexin 1 (43), whereas brefeldin A was used to block ATP exocytosis. Both blockers produced a partial inhibition of ATP release with different kinetics (Fig. 5A) . 
Volume Regulation Using a Small Assay Volume
If both ADP e (produced by exogenous Na ϩ -K ϩ -ATPase) and 2MetSADP activate RVD (Figs. 1 and 3, A and B) , and ADP e is produced under hypotonicity (Fig. 5B) , then a reduction of assay volume might enhance ADP e concentration and activate RVD. Accordingly, a threefold reduction in assay volume (from 300 to 100 l) produced an activation of RVD 40 from 40.8 Ϯ 7.80% (assay volume ϭ 300 l; Fig. 1 ) to 82.6 Ϯ 4.31% (assay volumeϭ100 l, Fig. 5C ; P Ͻ 0.01). This enhanced RVD 40 was blocked in similar experiments using 50 M MRS2211 (a blocker of P2Y 13 ) or 100 M POM-1 (an inhibitor of ectoATPase activity), i.e., in a small hypotonic assay volume, RVD 40 with MRS2211 (45.9 Ϯ 3.93%) or POM-1 (25.8 Ϯ 6.35%) did not differ from that obtained using a standard assay volume in the absence of these inhibitors.
Huh-7 Cells Showed ectoATPase Activity
For Huh-7 cells under hypotonicity, the observed decrease of [ATP] e after achieving a maximum suggests the existence of significant ectoATPase activity that can be assigned to one or more ectonucleotidases.
By following the release of 32 P i from [ 32 ␥P]ATP we studied ectoATPase activity of intact Huh-7 cells under isotonic and hypotonic conditions in a wide range of, physiologically relevant, ATP concentrations (50 -1,600 nM). EctoATPase activity was similar in hypo-and isotonic media (Fig. 6A ) and increased with [ATP] e in an hyperbolic pattern, with K 0.5 ϭ 333.2 Ϯ 83.44 nM (Fig. 6A) . In the lower part of the curve, the apparent rate constant describing ectoATPase activity was k ATP ϭ 0.15 Ϯ 0.007 fmol P i ϫ (s ϫ 5 ϫ 10 4 cells) Ϫ1 (Fig.  6B ). This constant was used to model the kinetics of ATP e accumulation as described in the APPENDIX.
Regarding the enzyme(s) responsible for ectoATPase activity, RT-PCR analysis of all ENTPDases subtypes allowed identification of a transcript only for ENTPDase 2 (Fig. 6C) .
Modeling ATP e Kinetics of Hypotonically Challenged Huh-7 Cells
The results above showed that swollen Huh-7 cells released ATP and that ectoATPase activity mediated ADP generation. We next built a mathematical model to quantify how these processes control ATP e kinetics and to predict transmembrane ATP fluxes that mediate ATP release.
In the model, ATP release in hypotonically challenged Huh-7 cells is mediated by one or more nonlytic transport mechanisms collectively denoted as J NL . Two J NL subfluxes account for the fact that both brefeldin A (a blocker of exocytosis) and carbenoxolone (a blocker of conductive ATP release) were able to partially inhibit ATP e accumulation.
Once in the extracellular medium, the model considers that ATP e can be hydrolyzed by ectoATPase activity. Empirical equations derived from experimental data of Fig. 5A and Fig.  6 were fed into the model (see APPENDIX for details). As shown in Fig. 7A , the model simulates the kinetics of ATP e with reasonable accuracy, so that values of best fit for the different parameters could be obtained (see Table A1 of APPENDIX). Modeling shows the transition from a steady, isotonic [ATP] e level to nonlinear changes in ATP e concentration under the different conditions (medium H, medium H ϩ brefeldin A, and medium H ϩ carbenoxolone).
The model predicts that the role of ectoATPase activity in determining ATP e kinetics is important, since running the simulation, with best fit parameters, in the absence of ATP e consumption (i.e., mathematically blocking the function describing ectoATPase activity vs.
[ATP] e ) causes ATP e concentrations to depart strongly from experimental data and attained much higher values (Fig. 7A, inset) . Figure 7B showed the predicted J NL fluxes in the absence of inhibitors (J NL ) or in the presence of either brefeldin A (J NL -H ϩ BfA) or carbenoxolone (J NL -H ϩ Cbx). Following the hypotonic challenge, J NL showed a steep, 12-fold increase to 7.8 Ϯ 0.62 nM/min after 12 min, followed by a slower nonlinear decrease to a constant value of 4.4 Ϯ 0.11 nM/min. Regarding the subfluxes, it can be seen that the nonexocytotic flux J NL -H ϩ BfA, representing conductive ATP release, was initially rapid, but unlike J NL it decreased equally fast to a constant value of 1.9 Ϯ 0.1 nM/min. The carbenoxolone insensitive flux, on the other hand, presented a different kinetics: there was a much slower initial increase (17-fold lower than J NL -H ϩ BfA) to a constant value where it remained constant thereafter (2.3 Ϯ 0.10 nM/min). The sum of both partial fluxes was smaller than the total J NL flux.
DISCUSSION
Results show that Huh-7 cells, when exposed to hypotonicity, are able to release ATP and at the same time exhibit swelling followed by RVD.
A main goal of this study was to clarify how these processes are related, with special focus on the role of ATP release, ectoATPase activity and P receptor activation on volume regulation of Huh-7 cells.
Under hypotonicity, these cells exhibited an RVD 40 amounting to 41%. At first glance, the fact that suramin ϩ cibacron blue inhibited 71% of the RVD pointed to a role of P receptor signaling on volume regulation, but additional experiments contradicted this view. That is, addition of an excess of pure apyrase, a remover of extracellular di-and trinucleotides, did not affect RVD, while a similar treatment blunted the RVD response in different cell systems including hepatocytes from various vertebrate species and murine hepatoma cells (21, 50, 59) .
The fact that in tracheal epithelium suramin and cibacron blue block Cl Ϫ permeability (25) , which is an effector of volume regulation in hepatic and hepatoma cells, would point to a direct effect of these compounds on the efflux of osmolytes during RVD. This is in line with experiments showing that glibenclamide, an inhibitor of volume-sensitive chloride channels (41) , was able to block RVD of swollen Huh-7 hepatoma cells.
Thus, up to here, the lack of effect of apyrase should indicate that extracellular nucleotides were not mediating RVD. However, unexpectedly, addition of pure Na ϩ -K ϩ -ATPase to hypotonically exposed cells, far from removing RVD, it enhanced RVD 40 from 41% to full volume regulation. Whereas apyrase activity is assumed to generate monophosphate nucleotides (AMP from ATP and/or UMP from UTP), which do not signal to P receptors, Na ϩ -K ϩ -ATPase promotes ATP e hydrolysis to ADP e . Thus there seems to be a basal RVD (i.e., RVD 40 Ϸ40%) which, according to apyrase experiments, is independent of extracellular nucleotides, whereas in hypotonic medium containing an excess of exogenous Na ϩ -K ϩ -ATPase, all released ATP e would be converted to ADP e , with the latter being able to activate specific P receptors and further enhance RVD until cell volume is downregulated to near isotonic values (i.e., RVD 40 Ϸ100%). To our knowledge there are no previous reports, for any cell type, of ADP e , derived from ATP e hydrolysis, strongly activating RVD.
In principle, three P2Y receptors are preferentially activated by ADP: P2Y 1 , P2Y 12 , and P2Y 13 (1) . Activation of P2Y1 receptors is transduced as increases in [Ca 2ϩ ] i , whereas P2Y 12 and P2Y 13 are linked to activation of G i , which can lead to inhibition of adenylyl cyclases and therefore to a decrease of cAMP concentration. Despite the detection of P2Y 1 transcripts in both Huh-7 and HepG2 cells, almost no increase of [Ca 2ϩ ] i was observed in response to ADP e , suggesting the lack of functional P2Y 1 receptors in these cell lines (30, 56) . Similarly, in our hands, exposure of Huh-7 (and HepG2 cells; data not shown) to hypotonic medium, both in the absence and presence of 2MetSADP (a potent ADP-P2Y receptor agonist), did not affect Ca i 2ϩ (Fig. 4, A and B) , thus suggesting the absence of On the other hand, our RT-PCR analysis revealed the presence of transcripts for P2Y 13 , but not for P2Y 12 (Fig. 3C) , and P2Y 13 was identified by Western blot analysis (Fig. 3D) . As shown in Fig. 4C , for Huh-7 cells under hypotonicity, 2MetSADP alone or in combination with forskolin was unable to alter cAMP concentration.
Similarly, in Chinese hamster ovary cells expressing P2Y 13 receptor, exposure to nanomolar ADP e did not modify cAMP levels (42) .
As a last proof of the role of ADP-P2Y 13 on RVD, 2MetSADP led to a similar activation of RVD as that observed in the presence of Na ϩ -K ϩ -ATPase, whereas the same ADP analog did not affect RVD when coincubated with MRS2211, a well-known blocker of P2Y 13 (34) .
Despite the above described evidence for ADP e involvement in autocrine/paracrine activation of RVD, a question remained open; if ATP e ¡ ADP e conversion by exogenous Na ϩ -K ϩ -ATPase activity enhanced RVD, then endogenous ectoATPase activity (Fig. 6) should also increase ADP e concentration to a certain extent and activate RVD. Then, apyrase hypotonic treatment, by removing ADP e , should, at least partially, inhibit the RVD response, but this was not observed in our experiments (Fig. 1) .
A possible explanation is that the lack of RVD activation by endogenous ADP e , derived from the accumulated ATP e , could be due to a relative low ectoATPase activity and the simultaneous dilution of ADP in the extracellular space. In this hypothetical scenario, reducing assay volume should lessen ADP e diffusion, increasing ADP e concentration at the surface of cells, thus activating RVD. Accordingly, when volumetric experiments of Fig. 1 were repeated in a 100-l assay volume (a volume one-third of that used in all other volumetric experiments) an increase in RVD 40 was observed. Moreover, this increase was blocked when similar experiments were run in the presence of the P2Y 13 blocker MRS2211 or in the presence of POM-1 (polyoxometalate-1), the latter a well-known blocker of ectoATPase activity (5) . This means that either blocking P2Y 13 activation, or blocking the conversion of ATP e to ADP e by ectoATPase activity, both prevent ADP e -mediated activation of RVD (Fig. 5C) .
Among the eight subtypes of NTPDases that differ in tissue distribution and substrate preference, only ENTPDases 1, 2, 3, 5, and 8 are cell surface enzymes. Importantly, whereas ENTPDases 1, 3, and 8 display relative high ectoATPase and ectoADPase activities, only ENTPDase 2 exhibits a high ectoATPase-to-ectoADPase ratio (62) . RT-PCR analysis on Huh-7 cells showed the presence of mRNA for ENTPDase 2 and the absence of mRNAs for all other ENTPDases (Fig. 6C) . Thus the observed ectoATPase activity of these cells can be assigned to ENTPDase 2 (Fig. 6, A and B) , whose activity should lead to the observed ADP e accumulation.
The prevalence of ENTPDase 2 in Huh-7 has also been observed in other human hepatomas as HepG2 (60) and Li-7A, as well as in lung carcinoma (35) . It has been suggested that its upregulated expression in these tumors might contribute to their proliferation by limiting apoptotic signaling by ATP e . Thus the ability of tumor hepatomas to use ATP e as a modulator of cell volume would be at risk, and ADP e might have been selected to replace ATP e as a signaling factor. Thus, although highly speculative to the moment, one could hypothesize a transition in the signaling process mediating RVD during the development of certain hepatic tumors. Human hepatocytes exhibit volume-dependent ATP release, with ATP e -P2Y receptor interaction being a critical determinant of Cl Ϫ permeability and cell volume regulation (21) . The action of ATP e is terminated by one or more ectonucleotidases like, e.g., ENTPDase 1. At least for human hepatoma Huh-7, the main activators of RVD are different, since following the hypotonic challenge, the exported ATP does not activate RVD but acts as a substrate for ENTPDase 2 to generate ADP e , which can then interact with P2Y 13 receptors to enhance RVD.
Exposure of these cells to hypotonic medium led to a nonlinear increase in [ATP e ] to a maximum, followed by a slower decay. In terms of the mathematical model proposed, the experimentally measured ATP e kinetics is compatible with an acute increase of ATP efflux (J NL in the model) to a maximum, followed by a slower decay towards a steady value significantly higher than the initial isotonic flux.
As shown in Fig. 7 , intracellular ATP appears to be released by at least two independent mechanisms, since carbenoxolone, a well-known blocker of conductive ATP release, and brefeldin A, an inhibitor of exocytosis, were both able to partially decrease the time-dependent accumulation of ATP e . Mathematical modeling showed that, upon hypotonic exposure, these two partial fluxes displayed different kinetics; the brefeldin A-resistant ATP flux increased acutely and decreased very rapidly to a final stationary value, while in the presence of carbenoxolone ATP efflux increased and decreased with much slower rates and did not reach a stationary value during the time interval of the experiments. The sum of both partial ATP fluxes was smaller than the total J NL flux, pointing to the existence of an additional subflux insensitive to both carbenoxolone and brefeldin A.
Although exocytosis was implicated in hypotonically induced ATP release of HTC rat hepatoma, human hepatocytes and cholangiocytes (21, 23, 26) , and turbot hepatocytes (47) , no previous report of a carbenoxolone-sensitive component of ATP release was reported for either hepatic or hepatoma cells. Carbenoxolone at a 10-M concentration has been used in many cell systems as a specific blocker of pannexin 1, which was postulated to form hexameric pores that allow passive transport of ATP across the plasma membrane (18) .
The observed ATP e kinetics does not only depend on the rate of ATP release but also on the capacity of ectonucleotidases to catalyze the hydrolysis of ATP e . Indeed, Huh-7 cells exhibited a significant ectoATPase activity that displayed a linear dependence on ATP e concentrations within a wide range of nanomolar concentrations (Fig. 6B) . The model predicted that the role of ectoATPase activity in determining ATP e kinetics is important, since running the simulation, with best fit parameters, in the absence of ATP e degradation (i.e., mathematically blocking the function describing ectoATPase activity vs.
[ATP] e ) caused ATP e concentrations to depart strongly from experimental data and attained much higher values (Fig. 6A,  inset) .
Thus our observations support a model in which there are two distinct signaling pathways required for volume recovery after swelling of Huh-7 cells exposed to hypotonic medium. One pathway is independent of purinergic signaling and allows cells to recover their volume only partially (Ϸ40%). The second pathway proposed involves full volume recovery from swelling through an ADP-P2Y 13 pathway. According to the scheme depicted in Fig. 8 , hypotonic medium would trigger ATP release by exocytosis and one or more conductive pathways, with at least one of these mediated by pannexin 1. Once in the extracellular milieu, the ongoing conversion of ATP e to ADP e by ENTPDase 2 activity would promote the accumulated ADP to activate P2Y 13 receptors in a paracrine/autocrine manner, followed by a chain of intracellular events leading to efflux of ions and water, thus activating a regulatory response that provides full recovery of cell volume.
APPENDIX
Modeling of ATPe Kinetics of Hypotonically Challenged Huh-7 Cells
A mathematical model was built to account for the experimentally observed ATP e kinetics when Huh-7 cells were sequentially exposed to isotonic and hypotonic media.
In the model, [ATP] e is controlled by 1) the rate of nonlytic ATP release (JNL), which accounts for one or more mechanisms allowing ATP efflux in the absence of lysis, and 2) the rate of ATP consumption by ectoATPase activity (J V).
In the model, time-dependent changes in [ATP]e are given by
where J NL and JV are the fluxes of ATP release and of ATP hydrolysis, respectively.
Rate of ATP consumption (J v).
In the model, JV denotes the flux of ATP consumption mediated by ectoATPase activity. The expression for JV was derived empirically after analyzing data of ectoATPase activity assayed in intact Huh-7 cells under hypotonic conditions (i.e., similar conditions as those used to measure ATPe kinetics) over an ample range of ATPe concentrations (50 -1,600 nM). In a first approach a hyperbolic function was fitted to experimental data of Fig. 6A .
The term V max represents the apparent maximal value of ectoATPase activity, and K0.5 the concentration of ATPe at which half-maximal activity is obtained, under the specific conditions of the experiment.
Since the model was used to simulate the experimentally obtained ATP e concentrations, which lie at least eight times lower than the K0.5, under this condition JV can be best described by a linear function of [ATP]e as:
with k ATP ϭ V max ⁄ K 0.5 .
Given that ectoATPase activity at different ATP concentrations is similar under isotonic and hypotonic conditions, it was assumed that k ATP remained constant during the simulation.
Nonlytic release of ATP (JNL).
Following hypotonic exposure of Huh-7 cells, the nonlinear accumulation of ATPe observed in Fig. 5A can be explained by assuming time-dependent changes in the flux of ATP release (J NL), which can be modeled as the transition through three different states of flux. Accordingly, in the unstimulated condition, there is a basal, isotonic, stationary state of flux (i). The hypotonic stimulus induces a transition to a stimulated state (s), followed by a final stationary state (f). The isotonic-hypotonic transition is formulated as the following irreversible two-step process:
as mentioned above xi, xs, and xf represent fractional contributions to total ATP release (see Fig. A1 ). These quantities display values from 0 to 1 and at every time are related by:
The net flux of ATP release is given by:
As such JNL is fully determined by the sum of each of three states (i, s, and f). Since Ji, Js, and Jf do not change with time, the time course of JNL is controlled by the time dependence of xi, xs, and xf. Before the hypotonic stimulus,
To simulate the transition from isotonic to hypotonic conditions, these values are held constant until the stimulus is applied. Fig. 7B and Table A1 ).
1)
A two-state model, in which there is a single transition from the initial to the final state (x i ¡xf), predicts a monotonous increase of [ATP]e, no matter whether this transformation is reversible or irreversible, and thus could not explain the experimentally observed ATPe kinetics.
2) By assuming a three state model (xi, xs, and xf), similar to the final model used for the simulations (i.e., Eq. 9), except that Ji ϭ Jf (i.e., an homeostatic response of the flux), the simulation fitted to experimental data, but according to the Akaike criterion (2), the bias was much larger than in the model presented in this study, where Ji Jf.
Model fitting. Best fitting values for J s, Jf, k1, and k2 and their associated standard errors were obtained with Copasi software, version 4.7. The Copasi file describing the model is available upon request.
Simulations were run in Libreoffice 3.3. 4 spreadsheets by introducing the integrated equations for [ATP] e and JNL. Standard errors for mean JNL values (Fig. 7) were computed from the covariance matrix of the model parameters using the approximated formula:
where Z is a random variable that is a function of random variables Y i.
